|
|
|
|
LEADER |
00000cam a2200000Mi 4500 |
001 |
EBSCO_on1286499979 |
003 |
OCoLC |
005 |
20231017213018.0 |
006 |
m d |
007 |
cr ||||||||||| |
008 |
211128s2021 si o ||| 0 eng d |
040 |
|
|
|a YDX
|b eng
|c YDX
|d Z5A
|d OCLCF
|d N$T
|d OCLCO
|
019 |
|
|
|a 1286386036
|a 1286422168
|
020 |
|
|
|a 9814998427
|q (electronic bk.)
|
020 |
|
|
|a 9789814998420
|q (electronic bk.)
|
035 |
|
|
|a (OCoLC)1286499979
|z (OCoLC)1286386036
|z (OCoLC)1286422168
|
050 |
|
4 |
|a RB56.5.A58
|
082 |
0 |
4 |
|a 615.7/92
|2 23/eng/20221202
|
049 |
|
|
|a UAMI
|
245 |
0 |
0 |
|a Frontiers in anti-Infective agents.
|n Volume 6
|h [electronic resource] /
|c editors: Parvesh Singh, Vipan Kumar, Rajshekhar Karpoormath.
|
260 |
|
|
|a Singapore :
|b Bentham Science Publishers,
|c 2021.
|
300 |
|
|
|a 1 online resource.
|
505 |
0 |
0 |
|t Anti-Infective Agents in Ocular Treatment and New Approaches --
|t Propitious Development of Vaccines for SARS-CoV --
|t Potassium Permanganate, the Vikut® Formula, an Innovation using non-antibiotic Antimicrobial Agents to Treat both Chronic and Non-chronic Wounds: A Clinical Approach with Scientific Evidence --
|t Approaches to Anti Infective Therapies --
|t Anti-infective Agents against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2) --
|t Bilayer Tablet - Approach for the Treatment of Sexually Transmitted Diseases with Fixed Dose Combination.
|
590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
650 |
|
0 |
|a Anti-infective agents.
|
650 |
|
2 |
|a Anti-Infective Agents
|
650 |
|
6 |
|a Antiinfectieux.
|
650 |
|
7 |
|a Anti-infective agents
|2 fast
|
700 |
1 |
|
|a Singh, Parvesh,
|e editor.
|
700 |
1 |
|
|a Kumar, Vipan,
|e editor.
|
700 |
1 |
|
|a Karpoormath, Rajshekhar,
|e editor.
|
856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=3104709
|z Texto completo
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 302598291
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 3104709
|
994 |
|
|
|a 92
|b IZTAP
|